Eric Van Den Neste - Concepedia

Author

Eric Van Den Neste

Cliniques Universitaires Saint-Luc ORCID

Also Known As

E Van Den Neste, E. Van Den Neste, E. Van den Neste, E. van den Neste, Eric Van Den Neste, Eric Van den Neste, Eric Van den Neste, Eric van den Neste, Van Den Neste, Eric

148

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Cliniques Universitaires Saint-Luc UCLouvain de Duve Institute Sorbonne Université Pitié-Salpêtrière Hospital

About

Eric Van Den Neste is an author at Cliniques Universitaires Saint-Luc specializing in medicine, hematology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	986
2	Health Sciences	5	5	163
3	Natural Sciences	4	4	159
4	Public Health	1	1	125
5	Allergy	1	1	38

Eric Van Den Neste

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification Basile Stamatopoulos, Nathalie Meuleman, Benjamin Haibe‐Kains, Blood	2009	243
High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia Marlène Pasquet, Christine Bellanné‐Chantelot, Suzanne Tavitian, Blood	2012	206
Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients Jean Donadieu, Marie Lamant, Claire Fieschi, Haematologica	2018	173
Atrial fibrillation in <scp>CLL</scp> patients treated with ibrutinib. An international retrospective study Philip A. Thompson, Vincent Lévy, Constantine S. Tam, British Journal of Haematology Heart FailureClinical ConsequencesCardiovascular PharmacologyCll PatientsPharmacotherapy	2016	125
Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine Eric Van Den Neste, V. Robín, Julie Francart, Leukemia Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematology	2007	88
Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine Peng Huang, Alex Sandoval, Eric Van Den Neste, Leukemia Hematological MalignancyMedicineImmunologyLong Non-coding RnaAdult T-cell Leukemia-lymphoma	2000	88
Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, Blood Advances	2021	77
Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC Laurent Sutton, Sylvie Chevret, Olivier Tournilhac, Blood	2011	69
Identification of in Vivo Phosphorylation Sites on Human Deoxycytidine Kinase Caroline Smal, Didier Vertommen, Luc Bertrand, Journal of Biological Chemistry Deoxycytidine KinaseMolecular BiologyRedox BiologyCellular PhysiologyOxidative Stress	2005	58
Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory study Yves Libert, Cindy Borghgraef, Yves Béguin, Psycho-Oncology	2016	55

Page 1